President Trump announces his admin. is providing an emergency use authorization for convalescent plasma to treat COVID-19, a treatment that more than 70,000 patients have already received.
to treat hospitalized COVID-19 patients, which the agency said carries too many risks without any apparent benefit.
"They want to do things the way they’ve always done it," Meadows said of career staffers at the FDA."This president is about cutting red tape. That’s what the tweet was all about." In July, former Vice President Joe Biden, the 2020 Democratic presidential nominee, called on Trump to"assure us all that the White House will respect the independent authority of the FDA to decide, free from political pressure, if the vaccine is safe and effective."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump and FDA announce new method to treat hospitalized COVID-19 patientsThe president said the new, expedited method of treatment has led to a reduced mortality rate by 35 percent in coronavirus patients.
Read more »
Trump repeats chloroquine COVID-19 claims, accuses FDA of sabotaging vaccine trialsU.S. President Donald Trump suggested that the 'deep state' at the FDA deliberately delayed developing a COVID-19 vaccine.
Read more »
Trump Accuses FDA Of 'Deep State' Conspiracy Against Him Over COVID-19 Vaccine TestingNancy Pelosi says accusation goes 'beyond the pale,' even for Trump, 'in terms of how he would jeopardize' Americans' health to serve his reelection.
Read more »
The FDA Authorized The Use Of Convalescent Plasma To Treat COVID-19Scientists say plasma collected from the blood of patients who have recovered from COVID-19 may be beneficial, but rigorous trials have not yet proven that it’s an effective treatment.
Read more »
FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19President Trump announced that the Food and Drug Administration granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on 'promising' results.
Read more »